Lotus Eye Hospital & Institute Ltd
₹98.22
(-4.38%)
Wed, 01 Apr 2026, 11:16 pm
Health Services
Medical/Nursing Services
24.5KLotus Eye Hospital & Institute EV/EBITDA Ratio
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 50.18 | 0 | 53.19 | 0 | 37.45 | 303 | 0 | 319 | 175.95 | 33.27 | 65.07 | 45.52 | 55.57 | 37.18 | 29.62 | 40.32 | 196.62 |
| Price to book ratio | 0 | 0 | 1.10 | 0.94 | 0.44 | 0.34 | 0.30 | 0.25 | 0.52 | 0.67 | 1.54 | 1.15 | 0.92 | 0.95 | 1.65 | 2.03 | 2.10 | 1.98 | 2.42 |
| Price to sales ratio | 0 | 0 | 5 | 3.52 | 1.21 | 0.67 | 0.54 | 0.44 | 0.86 | 1.07 | 2.27 | 1.53 | 1.20 | 1.19 | 2.69 | 2.85 | 2.57 | 2.44 | 2.93 |
| Price to cash flow ratio | 0 | 0 | 0 | 6.56 | 2.53 | 6.72 | 3.99 | 3.16 | 10.62 | 9.43 | 23.50 | 9.58 | 11.14 | 9.07 | 28.43 | 23.53 | 25.39 | 19.31 | 53.80 |
| Enterprise value | 0 | 0 | 613.52M | 503.24M | 225.73M | 175.46M | 135.11M | 118.55M | 259.78M | 313.6M | 739.18M | 546.08M | 437.9M | 421.55M | 776.21M | 1.03B | 1.13B | 1.12B | 1.45B |
| Enterprise value to EBITDA ratio | 0 | 0 | 17.45 | 16.01 | 6.13 | 9.67 | 3.71 | 3.56 | 10.76 | 7.59 | 21.97 | 12.40 | 13.53 | 10.53 | 21.26 | 17.39 | 14.61 | 16.62 | 40.64 |
| Debt to equity ratio | 0.48 | 0.42 | 0.12 | 0.03 | 0.02 | 0.01 | 0.02 | 0 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.06 |
| Return on equity % | 0 | 7.91 | 3.29 | -0.45 | 0.82 | -4.33 | 0.81 | 0.08 | -3.93 | 0.20 | 0.89 | 3.47 | 1.41 | 2.10 | 3.02 | 5.56 | 7.27 | 4.98 | 1.24 |
Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio
The Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Lotus Eye Hospital & Institute Ltd's valuation, profitability, and overall financial performance. Tracking the Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Lotus Eye Hospital & Institute Ltd (NSE: LOTUSEYE, BSE: 532998) is currently trading at ₹98.22, with a market capitalization of ₹2.11B. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio Current Value
The current Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio stands at 40.64.
The latest Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 40.64
- 2023: 16.62
- 2022: 14.61
- 2021: 17.39
- 2020: 21.26
The recent rise in Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.
What Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Lotus Eye Hospital & Institute Ltd.
Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Lotus Eye Hospital & Institute Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800